Cargando…
Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial
BACKGROUND: The role of remdesivir in the treatment of patients in hospital with COVID-19 remains ill defined in a global context. The World Health Organization Solidarity randomized controlled trial (RCT) evaluated remdesivir in patients across many countries, with Canada enrolling patients using a...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
CMA Impact Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863204/ https://www.ncbi.nlm.nih.gov/pubmed/35045989 http://dx.doi.org/10.1503/cmaj.211698 |
Ejemplares similares
-
Remdesivir Efficacy in COVID-19 Treatment: A Randomized Controlled Trial
por: Abd-Elsalam, Sherief, et al.
Publicado: (2022) -
Health Canada: AKI or ARF with remdesivir for COVID-19?
Publicado: (2021) -
Remdesivir and corticosteroids in the treatment of hospitalized COVID-19 patients
por: Coelho, Luís, et al.
Publicado: (2023) -
Remdesivir for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials
por: Al-Abdouh, Ahmad, et al.
Publicado: (2021) -
Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial
por: Rosas, Ivan O., et al.
Publicado: (2021)